Manifestation of leukoencephalopathy in a patient with advanced non-small cell lung cancer following treatment with gefitinib

被引：2
作者：
Huang Yi-sheng [1 ]
Huang Biao [2 ]
Wu Yi-long [1 ]
机构：
[1] Guangdong Gen Hosp, Guangdong Lung Canc Inst, Guangzhou 510080, Guangdong, Peoples R China
[2] Guangdong Gen Hosp, Dept Radiol, Guangzhou 510080, Guangdong, Peoples R China
来源：
CHINESE MEDICAL JOURNAL | 2011年 / 124卷 / 22期
关键词：
gefitinib; leukoencephalopathy; radiosensitizing; non-small cell lung cancer; RECEPTOR-TYROSINE KINASE; CENTRAL-NERVOUS-SYSTEM; RADIATION; BRAIN; INHIBITOR; NEUROTOXICITY; CHEMOTHERAPY; METHOTREXATE; RADIOTHERAPY; SURVIVAL;
D O I：
10.3760/cma.j.issn.0366-6999.2011.22.043
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The present case is a patient with advanced non-small cell lung cancer (NSCLC) who developed leukoencephalopathy following radiotherapy and gefitinib treatments. There are rarely reports of such incidences because the median survival period of advanced NSCLC is only ten months. The features of leukoencephalopathy in this case were atypical for radiation leukoencephalopathy, so it was suspected that the leukoencephalopathy was associated with gefitinib. Chin Med J 2011;124(22):3834-3837
引用
收藏
页码：3834 / 3837
页数：4
相关论文
共 50 条
  • [31] Pharmacokinetics of gefitinib in elderly patients with EGFR-mutated advanced non-small cell lung cancer: a prospective study
    Nio, Yuta
    Ishida, Hiroo
    Matsumoto, Natsumi
    Kusumoto, Sojiro
    Kubota, Yutaro
    Tsunoda, Takuya
    Sasaki, Yasutsuna
    Fujita, Ken-ichi
    BMC PULMONARY MEDICINE, 2022, 22 (01)
  • [32] GEFITINIB AS FIRST-LINE THERAPY FOR ADVANCED OR METASTATIC NON-SMALL CELL LUNG CANCER PATIENTS IN SOUTHERN TAIWAN
    Yang, Cheng-Ta
    Hung, Jen-Yu
    Lai, Chun-Liang
    Hung, Hsin-Chia
    Lai, Yung-Fa
    Lin, Meng-Chih
    Shieh, Jiunn-Min
    Huang, Ming-Shyang
    KAOHSIUNG JOURNAL OF MEDICAL SCIENCES, 2010, 26 (01) : 1 - 7
  • [33] Basic Clinical Parameters Predict Gefitinib Efficacy in Non-small Cell Lung Cancer
    Pircher, Andreas
    Ulsperger, Ernst
    Hack, Rene
    Jamnig, Herbert
    Pall, Georg
    Zelger, Bettina
    Sterlacci, William
    Hilbe, Wolfgang
    Fiegl, Michael
    ANTICANCER RESEARCH, 2011, 31 (09) : 2949 - 2955
  • [34] Gefitinib: a review of its use in adults with advanced non-small cell lung cancer
    Sohita Dhillon
    Targeted Oncology, 2015, 10 : 153 - 170
  • [35] Gefitinib: a review of its use in adults with advanced non-small cell lung cancer
    Dhillon, Sohita
    TARGETED ONCOLOGY, 2015, 10 (01) : 153 - 170
  • [36] Erlotinib and Gefitinib for Elderly Patients with Advanced Non-small-cell Lung Cancer
    Passaro, Antonio
    Alesini, Daniele
    Pochesci, Alessia
    Cortesi, Enrico
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2014, 14 (05) : 646 - 650
  • [37] A population-based study of gefitinib in patients with non-small cell lung cancer
    Hayashibara, Kenji
    Satoh, Hiroaki
    Shinohara, Yoko
    Inagaki, Masaharu
    Kaburagi, Takayuki
    Hashimoto, Toshio
    Kurishima, Koichi
    Ishikawa, Hiroichi
    Ichimura, Hideo
    Nawa, Takeshi
    Funayama, Yasunori
    Matsumura, Takeshi
    Kagohashi, Katsunori
    Endo, Takeshi
    Furukawa, Kinya
    Kishi, Koji
    Sumi, Masaaki
    Kamiyama, Koichi
    Ishikawa, Shigemi
    MEDICAL ONCOLOGY, 2009, 26 (02) : 222 - 227
  • [38] Treatment of advanced non-small cell lung cancer in the elderly
    Knetki-Wroblewska, Magdalena
    Pluzanski, Adam
    Krzakowski, Maciej
    ONCOLOGY IN CLINICAL PRACTICE, 2011, 7 (01): : 1 - 8
  • [39] CLINICAL STUDY OF BUFEI HUAYU DECOCTION COMBINED WITH GEFITINIB IN THE TREATMENT OF ADVANCED NON-SMALL CELL LUNG CANCER
    Feng Yuan
    Chen Sining
    Zhou Ying
    Xia Ze
    Lin Weinan
    Zhu Lin
    Song Shenge
    Wei Lulu
    Li Jianzhe
    Tang Fangmei
    Jiang Ying
    ACTA MEDICA MEDITERRANEA, 2020, 36 (03): : 1815 - 1821
  • [40] Chemoradiation Therapy Followed by Surgery in the Treatment of Locoregionally Advanced Non-Small Cell Lung Cancer
    Cohen, Charlotte
    Pop, Daniel
    Venissac, Nicolas
    Poudenx, Michel
    Otto, Josiane
    Castelnau, Olivier
    Mouroux, Jerome
    THORACIC AND CARDIOVASCULAR SURGEON, 2018, 66 (02) : 129 - 134
12345